Evidence map›Paper›PMID 39682024›Full record

ArticleLasers in surgery and medicine2025

Evaluation of Papain-Urea for Enzymatic Debridement of Coagulation Zones Following Ablative Fractional Laser Treatment.

Joshua Zev Glahn, Michael Wang-Evers, Abigail R Carlson, Haley Marks, Daniel Karasik, Felix Hilge, Jeremy Goverman, Dieter Manstein

Abstract readEvaluation Study
In one paragraph

Article in Lasers in surgery and medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joshua Zev GlahnDepartment of Dermatology, Harvard Medical School, Massachusetts General Hospital, Cutaneous Biology Research Center, Boston, Massachusetts, USA.
Michael Wang-EversDepartment of Dermatology, Harvard Medical School, Massachusetts General Hospital, Cutaneous Biology Research Center, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0002-6461-4891
Abigail R CarlsonDepartment of Dermatology, Harvard Medical School, Massachusetts General Hospital, Cutaneous Biology Research Center, Boston, Massachusetts, USA.
Haley MarksDepartment of Dermatology, Harvard Medical School, Massachusetts General Hospital, Cutaneous Biology Research Center, Boston, Massachusetts, USA.
Daniel KarasikDepartment of Dermatology, Harvard Medical School, Massachusetts General Hospital, Cutaneous Biology Research Center, Boston, Massachusetts, USA.
Felix HilgeDepartment of Dermatology, Harvard Medical School, Massachusetts General Hospital, Cutaneous Biology Research Center, Boston, Massachusetts, USA.
Jeremy GovermanDepartment of Surgery, Massachusetts General Hospital, Sumner Redstone Burn Center, Boston, Massachusetts, USA.
Dieter MansteinDepartment of Dermatology, Harvard Medical School, Massachusetts General Hospital, Cutaneous Biology Research Center, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAblative fractional CO

methodsEx vivo skin samples were treated with either control, papain, urea, or papain-urea solutions before being covered with occlusive dressing and incubated at 37°C for 1 h. Tissue viability as well as AZ and CZ geometries were assessed histologically.

resultsTreatment with all three experimental solutions resulted in a decrease in CZ. The largest average reduction in CZ area was observed in the papain-urea group (44%, p < 0.001), followed by the papain (14%, p < 0.001) and urea (11%, p < 0.001) only groups. Only the papain-urea group showed a significant increase in AZ (14%) and changes in lesion geometry.

conclusionThis exploratory study of enzymatic post-processing with papain-urea highlighted the potential of selectively removing the CZ after treatment with ablative fractional laser therapy. If results can be translated to in vivo studies, these findings could expand the use of high-fluence CO

Indexed as

DebridementLaser CoagulationLasers, GasPapainSkinUreaAnimalsIn Vitro TechniquesSwinePapainUreaablative fractional lasercoagulation zoneenzymatic debridementpapain–ureapost‐processingtranscutaneous drug delivery

Identifiers

PMID39682024
PMCPMC11776449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.